| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Vinpocetine EP Impurity A
|
40163-56-2 |
长春西汀相关物质A
|
VINPOCETINE-1;长春西汀相关物质A;长春胺乙酯
|
C22H28N2O3 |
368.474 | |
|
Vildagliptin Impurity 13
|
2577-48-2 |
METHYL L-PROLINATE
|
|
C6H11NO2 |
129.15704 | 219-932-6 |
|
Vildagliptin Impurity A
|
565453-39-6 |
维格列汀杂质 K
|
(S)-1-[[(3-羟基-1-金刚烷基)氨基]乙酰基]-2-酰胺基四氢吡咯烷;维格列汀杂质 4;维格列汀杂质 K;(S)-1-[2-(3-羟基-1-金刚烷胺基)-乙酰基]-2-羧基吡咯;维格列汀-10;维格列汀相关化合物D;索利那新杂质K;维格列汀羧酰胺杂质
|
C17H26N2O4 |
322.39934 | |
|
Vildagliptin Impurity 48
|
96166-39-1 |
维格列汀杂质C
|
Vildagliptin Impurity 22/(S)-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide;Vildagliptin Impurity 48;1-glycoloyl-L-proline amide;(S)-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide;2-Pyrrolidinecarboxamide,1-(hydroxyacetyl)-,(S)-(9CI);1-Glycoloyl-L-prolinamide
|
C7H12N2O3 |
||
|
Vildagliptin Carboxylic Acid Metabolite
|
565453-40-9 |
维格列汀杂质
|
(S)-1-[[(1-金刚烷基)氨基]乙酰基]-2-羧酸四氢吡咯烷;维格列汀杂质 3;维格列汀杂质27;N-(3-羟基金刚烷-1-基)甘氨酰-L-脯氨酸
|
C17H25N3O2 |
303.4 | |
|
Cyanuric acid
|
108-80-5 |
氰尿酸
|
1,3,5-三嗪-2,4,6-(1H,3H,5H)三酮;2,6-三(2'-羟基-4'-正丁氧基苯基)-1,5-三嗪;对称三羟基三氮杂苯;三嗪-5;异氰脲酸;2,6-三羟基-1,5-三嗪;氰脲酸;2,6-三(2'-羟基-4'-正丁氧基苯基)-1,5-三嗪
|
C3H3N3O3 |
129.07 | 203-618-0 |
|
Venlafaxine O-Desmethyl Cyclic Impurity
|
1346601-55-5 |
文拉法辛杂质
|
文拉法辛O-去甲基环杂质;O-去甲基文拉法辛循环杂质
|
C16H23NO2 |
261.35932 | |
|
Venlafaxine Impurity H
|
1329795-88-1 |
文拉法辛EP杂质H
|
文拉法辛杂质H;VENLAFAXINE-7;文拉法辛EP杂质H(碱)
|
C24H33NO3 |
383.52372 | |
|
Venlafaxine EP Impurity G
|
1076199-92-2 |
盐酸文拉法辛杂质G
|
文拉法辛杂质G(单体);盐酸文拉法辛杂质G;盐酸文拉法辛EP杂质G;文拉法辛杂质G;脱氧文拉法辛;文拉法辛EP杂质G
|
C17H27NO |
261.40238 | |
|
(2RS)-2-(Cyclohex-1-enyl)-2-(4-Methoxyphenyl)-N,N-diMethylethanaMine Hydrochloride
|
93413-79-7 |
盐酸文拉法辛杂质F
|
VENLAFAXINE-5;盐酸文拉法辛杂质F;文拉法辛杂质F;BETA-1-环己烯-1-基-4-甲氧基-N,N-二甲基苯乙胺盐酸盐;文拉法辛EP杂质F;文拉法辛杂质F盐酸
|
C17H26ClNO |
295.84744 | |
|
Venlafaxine EP Impurity E Hydrochloride
|
93413-56-0 |
盐酸文拉法辛杂质E
|
文拉法辛EP杂质E HCL;VENLAFAXINE-4;5-(4-甲氧基苯基)-3-甲基-1-氧杂-3-氮杂螺[5.5]十一烷盐酸盐;文拉法辛EP杂质E;盐酸文拉法辛杂质E;文拉法辛杂质E;杂质文拉法辛盐酸ê;盐酸文拉法辛EP杂质E
|
C17H26ClNO2 |
311.84684 | |
|
Venlafaxine Related Compound A (10 mg) (1-(1-(4-Methoxyphenyl)-2-(methylamino)ethyl)cyclohexanol hydrochloride)
|
93413-90-2 |
盐酸文拉法辛杂质D
|
N-去甲基盐酸文拉法辛 (文拉法辛杂质D);VENLAFAXINE-3;文拉法辛EP杂质D HCL;盐酸文拉法辛杂质D;文拉法辛杂质D;万拉法新相关物质A;1-[1-(4-甲氧基苯基)-2-(甲基氨基)乙基]环己醇盐酸盐;文拉法辛EP杂质D
|
C17H27NO2 |
277.40178 | |
|
(2S,5S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid
|
1335316-40-9 |
(5S)-N-(甲氧羰基)-L-缬氨酰-5-甲基-L-脯氨酸
|
沃拉帕韦中间体;VELPATASVIR 中间体;(5S)-N-(甲氧羰基)-L-缬氨酰-5-甲基-L-脯氨酸;(2S,5S)-1-((S)-2-((甲氧基羰基)氨基-3-甲基丁酰基)-5-甲基吡咯烷-2-羧酸;维帕他韦中间体-B;(5S)-N-(甲氧羰基)-L-缬氨酰-5-甲基-L-脯氨酸,沃拉帕韦中间体
|
C13H22N2O5 |
286.33 | 811-415-9 |
|
Vecuronium Bromide EP Impurity F
|
18668-29-6 |
维库溴铵杂质
|
维库溴铵EP杂质F
|
C26H41NO3 |
415.6139 | |
|
Vecuronium Bromide EP Impurity E
|
50587-95-6 |
维库溴铵相关物质B
|
维库溴铵相关物质B;维库溴铵相关物 B;维库溴铵EP杂质E
|
C32H55BrN2O3 |
595.6947 | |
|
Vecuronium Bromide EP Impurity D
|
73319-30-9 |
维库溴铵相关物质C
|
维库溴铵相关物质C;维库溴铵相关物 C
|
C30H53BrN2O2 |
553.65802 | |
|
3-Desacetyl Vecuronium Bromide
|
73319-13-8 |
维库溴铵EP杂质C
|
维库溴铵EP杂质C
|
C32H55BrN2O3 |
595.6947 | |
|
Vardenafil Impurity 16
|
1417529-67-9 |
伐地那非杂质1
|
伐地那非杂质1
|
|||
|
Vardenafil Impurity 5
|
912576-30-8 |
HYDROXYTHIO VARDENAFIL
|
HYDROXYTHIO VARDENAFIL;羟基硫代伐地那非
|
C23H32N6O4S2 |
520.66798 | |
|
Vardenafil EP Impurity C
|
1255919-03-9 |
伐地那非杂质D
|
伐地那非EP杂质C;伐地那非EP杂质C(伐地那非二聚体)
|
药智官方微信
药智官方微博
